Ligand validation:6FXY

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6FXY_NAG_A_808	6%	75%	0.23	0.651	0.37	0.59	-	1	0	0	100%	0.9333
6FXT_NAG_A_808	46%	82%	0.135	0.868	0.27	0.52	-	-	0	0	100%	0.9333
6FXX_NAG_A_810	40%	87%	0.167	0.879	0.24	0.44	-	-	0	0	100%	0.9333
6FXR_NAG_A_808	30%	77%	0.193	0.857	0.36	0.55	-	-	0	0	100%	0.9333
6TES_NAG_A_1006	21%	59%	0.183	0.79	0.81	0.78	1	1	0	0	100%	0.9333
6TEZ_NAG_A_808	20%	72%	0.209	0.813	0.43	0.66	-	1	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3PPS_NAG_B_760	100%	44%	0.028	0.993	0.57	1.57	-	3	0	0	100%	0.9333
5O59_NAG_A_601	100%	70%	0.024	0.993	0.3	0.85	-	-	0	0	100%	0.9333
5U7O_NAG_B_704	100%	88%	0.024	0.989	0.23	0.44	-	-	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.